BACKGROUND: Following an acute insult, macrophages regulate renal fibrogenesis through the release of various factors that either encourage the synthesis of extracellular matrix synthesis or the degradation of matrix via endocytosis, proteolysis, or both. However, the roles of infiltrating versus resident myeloid cells in these opposing processes require elucidation. The transcription factor Twist1 controls diverse essential cellular functions through induction of several downstream targets, including matrix metalloproteinases (MMPs). In macrophages, Twist1 can influence patterns of cytokine generation, but the role of macrophage Twist1 in renal fibrogenesis remains undefined. METHODS: To study Twist1 functions in different macrophage subsets during kidney scar formation, we used two conditional mutant mouse models in which Twist1 was selectively ablated either in infiltrating, inflammatory macrophages or in resident tissue macrophages. We assessed fibrosis-related parameters, matrix metallopeptidase 13 (MMP13, or collagen 3, which catalyzes collagen degradation), inflammatory cytokines, and other factors in these Twist1-deficient mice compared with wild-type controls after subjecting the animals to unilateral ureteral obstruction. We also treated wild-type and Twist1-deficient mice with an MMP13 inhibitor after unilateral ureteral obstruction. RESULTS: Twist1 in infiltrating inflammatory macrophages but not in resident macrophages limited kidney fibrosis after ureteral obstruction by driving extracellular matrix degradation. Moreover, deletion of Twist1 in infiltrating macrophages attenuated the expression of MMP13 in CD11b+Ly6Clo myeloid cells. Inhibition of MMP13 abrogated the protection from renal fibrosis afforded by macrophage Twist1. CONCLUSIONS: Twist1 in infiltrating myeloid cells mitigates interstitial matrix accumulation in the injured kidney by promoting MMP13 production, which drives extracellular matrix degradation. These data highlight the complex cell-specific actions of Twist1 in the pathogenesis of kidney fibrosis.
BACKGROUND: Following an acute insult, macrophages regulate renal fibrogenesis through the release of various factors that either encourage the synthesis of extracellular matrix synthesis or the degradation of matrix via endocytosis, proteolysis, or both. However, the roles of infiltrating versus resident myeloid cells in these opposing processes require elucidation. The transcription factor Twist1 controls diverse essential cellular functions through induction of several downstream targets, including matrix metalloproteinases (MMPs). In macrophages, Twist1 can influence patterns of cytokine generation, but the role of macrophage Twist1 in renal fibrogenesis remains undefined. METHODS: To study Twist1 functions in different macrophage subsets during kidney scar formation, we used two conditional mutant mouse models in which Twist1 was selectively ablated either in infiltrating, inflammatory macrophages or in resident tissue macrophages. We assessed fibrosis-related parameters, matrix metallopeptidase 13 (MMP13, or collagen 3, which catalyzes collagen degradation), inflammatory cytokines, and other factors in these Twist1-deficient mice compared with wild-type controls after subjecting the animals to unilateral ureteral obstruction. We also treated wild-type and Twist1-deficient mice with an MMP13 inhibitor after unilateral ureteral obstruction. RESULTS:Twist1 in infiltrating inflammatory macrophages but not in resident macrophages limited kidney fibrosis after ureteral obstruction by driving extracellular matrix degradation. Moreover, deletion of Twist1 in infiltrating macrophages attenuated the expression of MMP13 in CD11b+Ly6Clo myeloid cells. Inhibition of MMP13 abrogated the protection from renal fibrosis afforded by macrophage Twist1. CONCLUSIONS:Twist1 in infiltrating myeloid cells mitigates interstitial matrix accumulation in the injured kidney by promoting MMP13 production, which drives extracellular matrix degradation. These data highlight the complex cell-specific actions of Twist1 in the pathogenesis of kidney fibrosis.
Authors: Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu Journal: J Clin Invest Date: 2002-11 Impact factor: 14.808
Authors: G A McQuibban; G S Butler; J H Gong; L Bendall; C Power; I Clark-Lewis; C M Overall Journal: J Biol Chem Date: 2001-09-24 Impact factor: 5.157
Authors: Masaki Inada; Yingmin Wang; Michael H Byrne; Mahboob U Rahman; Chisato Miyaura; Carlos López-Otín; Stephen M Krane Journal: Proc Natl Acad Sci U S A Date: 2004-11-24 Impact factor: 11.205
Authors: Jun-O Deguchi; Elena Aikawa; Peter Libby; Jeffrey R Vachon; Masaki Inada; Stephen M Krane; Peter Whittaker; Masanori Aikawa Journal: Circulation Date: 2005-10-17 Impact factor: 29.690
Authors: G Angus McQuibban; Jiang-Hong Gong; Julie P Wong; John L Wallace; Ian Clark-Lewis; Christopher M Overall Journal: Blood Date: 2002-08-15 Impact factor: 22.113
Authors: Anna Henger; Matthias Kretzler; Peter Doran; Mahnaz Bonrouhi; Holger Schmid; Eva Kiss; Clemens D Cohen; Stephen Madden; Stefan Porubsky; Elisabeth F Gröne; Detlef Schlöndorff; Peter J Nelson; Hermann-Josef Gröne Journal: Kidney Int Date: 2004-03 Impact factor: 10.612
Authors: Dinesh K Ahirwar; Ramesh K Ganju; Manish Charan; Sanjay Mishra; Ajeet K Verma; Konstantin Shilo; Bhuvaneswari Ramaswamy Journal: Cancer Res Date: 2021-08-16 Impact factor: 13.312